Table 3 Ocular manifestations among patients with and without graft-versus-host disease.
Without cGVHD n = 22 (%) | With Chronic GVHD n = 60 (%) | p-value† | |
|---|---|---|---|
Conjunctival scarring | 0 (0.00) | 8 (13.33) | 0.007 |
Meibomian gland dysfunction | 16 (72.72) | 55 (91,66) | 0.001 |
Corneal opacity | 0 (0.00) | 4 (6.66) | 0.014 |
Filamentous keratitis | 0 (0.00) | 6 (10.00) | 0.001 |
Corneal neurotrophic ulcer | 0 (0.00) | 1 (1.66) | 0.497 |
Infectious keratitis | 0 (0.00) | 1 (1.66) | 0.541 |
Mucoid secretion | 0 (0.00) | 15 (25.00) | < 0.001 |
Corneal neovascularization | 0 (0.00) | 6 (10.00) | 0.001 |
Corneal perforation | 0 (0.00) | 2 (3.33) | 0.246 |
Cataract | 4 (18.18) | 17 (28.33) | 0.018 |
Retinopathy | 2 (9.09) | 4 (6.66) | 0.795 |
Ocular surgery | 2 (9.09) | 17 (28.33) | 0.009 |